United States: ScriptPro’s Claims Not A Prescription For Invalidity

The recent Federal Circuit case ScriptPro, LLC v. Innovation Associates, Inc., No. 2013-1561 (Fed. Cir. Aug. 6, 2014), reversed the trial court's summary judgment invalidity determination under 35 U.S.C. § 112, ¶1 (now § 112(a)).  For a claim to be valid, the patent's specification must describe the subject matter defined in the claims.  See Ariad Pharm., Inc. v. Eli Lilly & Co., 598 F.3d 1336, 1351 (Fed. Cir. 2010) (en banc).  Typically, § 112, ¶1 is used to invalidate claims where an added claim element does not have adequate support in the written description to show possession as of the filing date.  In somewhat the other direction, the district court in ScriptPro rested its invalidity holding on a single conclusion: "that the specification describes a machine containing 'sensors,' whereas the claims at issue claim a machine that need not have 'sensors.'" ScriptPro, slip op. at 2 (citing ScriptPro LLC v. Innovation Assocs., Inc., No. 06-2468, 2012 WL 2402778 (D. Kan. June 26, 2012)).  The Federal Circuit determined that claims lacking a fully described element from the specification do not, as a matter law, require a holding of invalidity. CITE

U.S. Patent No. 6,910,601 (the '601 patent) relates to a machine for sorting pills, and automatically filling and labeling the bottles for individual patients.  The invention was touted as enhancing the accuracy and efficiency of pharmacies generally, and, as a primary goal, allowing them to collate and store multiple containers for a patient within the same area.  Id. at 2-3 (citing '601 patent, 6:21-38).  Claim 1 reads:

1. A collating unit for automatically storing prescription containers dispensed by an automatic dispensing system, the collating unit comprising:

a storage unit for storing the containers delivered by an infeed conveyor;

a plurality of holding areas formed within the storage unit for holding the containers;

a plurality of guide arms mounted within the storage unit and operable to maneuver the containers from the infeed conveyor into the plurality of holding areas; and

a control system for controlling operation of the infeed conveyor and the plurality of guide arms.

'601 patent, 15:57-16:2.  Absent from the above claim, or any asserted claim in the '601 patent, is a "sensors" element.  See ScriptPro, slip op. at 4.  Yet, according to the specification, "[t]he collating unit of the present invention broadly includes" several components, including "a plurality of sensors, and a control system."  '601 patent, 4:26-29 (emphasis added); see also id., Abstract, 5:52-59 ("[T]he sensor positioned at the open end of the holding area determines if the holding area is full.").  The examples of the collating units, moreover, all included such sensors. The machine is depicted in Fig. 1, below, with sensors at 26:

ScriptPro sued Innovation Associates for patent infringement.  The district court construed claim terms and entertained cross-motions for summary judgment.  The court found that the specification indisputably limited the invention to machines employing sensors that determine whether holding areas are full, such that "no reasonable jury could find that the inventors were in possession of a collating unit that operated without sensors."  ScriptPro, 2012 WL 2402778, at *7.  Importantly, the court rejected as "entirely conclusory" the expert testimony opining that, based on the written description, the sensors were not required to practice the claimed invention.  Id.  The trial court granted summary judgment of invalidity, holding as a matter of law that the patent's specification does not describe the subject matter of the asserted claims, which do not require sensors.  See ScriptPro, slip op. at 6.

In a unanimous Federal Circuit opinion, the authoring Judge Taranto identified the narrow the issue on review: "whether the absence of sensors from the claims at issue means that those claims are unsupported by the written description as a matter of law."  Id. at 7.  The court taught with respect to this sole issue that

It is common, and often permissible, for particular claims to pick out a subset of the full range of described features, omitting others.  A specification can adequately communicate to a skilled artisan that the patentee invented not just the combination of all identified features but combinations of only some of those features (subcombinations)—which may achieve stated purposes even without omitted features.
ScriptPro

, slip op. at 7-8 (citations omitted).  According to the Federal Circuit, on the facts of the case, the specification's description of embodiments as having sensors for providing information about slot allocations "does not necessarily mean that the only described invention is a collating unit with such sensors."  Id. at 7 (emphasis added). 

The court articulated numerous reasons for its determination.  First, the specification was found to have "no sufficiently clear language" limiting the invention to only a collating unit with sensors.  Id. at 8.  Even the specification's declaration that the present invention "broadly comprises" sensors as part of the collating unit was not enough to support the summary judgment conclusion.  Id. at 8 ("Like 'generally,' the qualifier 'broadly' suggests that exceptions are allowed to the assertion of what occurs most (perhaps even almost all) of the time.").  Second, according to the court, "the specification in describing the preferred embodiment, elsewhere positively suggests that slot sensors are an optional, though desirable feature of the contemplated collating unit."  Id. at 9.  Third, a lack of sensors was not deemed incommensurate with the central purpose of the invention, i.e., correlating a specific holding area to a specific patient.  Id. at 8.  Fourth, ScriptPro's expert report suggested that a collating unit could operate without sensors, keeping track instead with computer memory what storage locations are available.  Id. at 11.  Fifth, the court noted that, as filed, the original claims also lacked sensors, which could serve to indicate that they have always been "merely optional."  Id. at 11-12 ("When a specification is ambiguous about which of several features are stand-alone inventions, the original claims can help resolve the ambiguity . . . ."). 

Accordingly, the court held that the patent's specification did not preclude, as a matter of law, ScriptPro from establishing that the written description conveys to one of skill that the inventors were in possession of the sensorless inventions of claims 1, 2, 4, and 8.  The court reversed the summary judgment determination.

It is well-understood that claims should be limited to the supporting disclosure.  But this case reaffirms that applicants can choose to claim only a subset of the full array of described features, leaving others unclaimed.  In other words, while there may be an adequate description for an entire combination of elements, claiming mere subcombinations of the identified features does not necessarily render a claim invalid under § 112, as a matter of law.  It is advisable, notwithstanding, for practitioners to clearly and adequately describe not just the combination of all elements, but also embodiments that may have only some elements deemed optional.

This article previously appeared in Full Disclosure Patent Newsletter, September 2014.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Events from this Firm
16 Jan 2019, Conference, Washington, DC, United States

Finnegan partner Lionel Lavenue will present “The Technology Accelerates: IP Issues at the Cutting Edge” during the Embry-Riddle Aeronautical University Aviation Law & Insurance Symposium.

17 Jan 2019, Webinar, Washington, DC, United States

As a part of Strafford Publications’ webinar series, Finnegan partners Erika Arner and Michael Flibbert

will discuss best practices for preparing a PTAB case for appeal to the Federal Circuit.

22 Jan 2019, Webinar, Washington, DC, United States

As part of Strafford Publications’ webinar series, Finnegan partners Shana Cyr and Mark Feldstein will provide essential updates on FDA practice and patent law relating to biologics and biosimilars.

Similar Articles
Relevancy Powered by MondaqAI
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions